Dual Face of Vγ9Vδ2-T Cells in Tumor Immunology: Anti-versus Pro-Tumoral Activities

被引:50
作者
Xiang, Zheng [1 ]
Tu, Wenwei [1 ]
机构
[1] Univ Hong Kong, Li Ka Shing Fac Med, Dept Paediat & Adolescent Med, Lab Translat Immunol, Hong Kong, Hong Kong, Peoples R China
来源
FRONTIERS IN IMMUNOLOGY | 2017年 / 8卷
关键词
V gamma 9V delta 2-T cells; antitumor activity; pro-tumor activity; tumor immunity; tumor immunotherapy; DELTA-T-CELLS; TCR-GAMMA-DELTA; PRENYL PYROPHOSPHATE ANTIGENS; BREAST-CANCER PATIENTS; EPSTEIN-BARR-VIRUS; PERIPHERAL-BLOOD; ADOPTIVE IMMUNOTHERAPY; IMMUNE-RESPONSES; ZOLEDRONIC ACID; DENDRITIC-CELLS;
D O I
10.3389/fimmu.2017.01041
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
V gamma 9V delta 2-T cells are considered as potent effector cells for tumor immunotherapy through directly killing tumor cells and indirectly regulating other innate and adaptive immune cells to establish antitumoral immunity. The antitumoral activity of V gamma 9V delta 2-T cells is governed by a complicated set of activating and inhibitory cell receptors. In addition, cytokine milieu in tumor microenvironment can also induce the pro-tumoral activities and functional plasticity of V gamma 9V delta 2-T cells. Here, we review the anti-versus pro-tumoral activities of V gamma 9V delta 2-T cells and discuss the mechanisms underlying the recognition, activation, differentiation and regulation of V gamma 9V delta 2-T cells in tumor immunosurveillance. The comprehensive understanding of the dual face of V gamma 9V delta 2-T cells in tumor immunology may improve the therapeutic efficacy and clinical outcomes of V gamma 9V delta 2-T cell-based tumor immunotherapy.
引用
收藏
页数:13
相关论文
共 50 条
  • [11] Vγ9Vδ2-T lymphocytes have impaired antiviral function in small-for-gestational-age and preterm neonates
    Li, Jinrong
    Li, Hong
    Mao, Huawei
    Yu, Meixing
    Feng, Ting
    Yang, Fan
    Fan, Yingying
    Lu, Qiao
    Shen, Chongyang
    Yin, Zhongwei
    Tu, Wenwei
    Mao, Meng
    CELLULAR & MOLECULAR IMMUNOLOGY, 2013, 10 (03) : 253 - 260
  • [12] An Update on the Molecular Basis of Phosphoantigen Recognition by Vγ9Vδ2 T Cells
    Herrmann, Thomas
    Fichtner, Alina Suzann
    Karunakaran, Mohindar Murugesh
    CELLS, 2020, 9 (06) : 1 - 26
  • [13] Emerging Challenges of Preclinical Models of Anti-tumor Immunotherapeutic Strategies Utilizing Vγ9Vδ2 T Cells
    Joalland, Noemie
    Scotet, Emmanuel
    FRONTIERS IN IMMUNOLOGY, 2020, 11
  • [14] Beyond CAR T cells: Engineered Vγ9Vδ2 T cells to fight solid tumors
    Rafia, Chirine
    Harly, Christelle
    Scotet, Emmanuel
    IMMUNOLOGICAL REVIEWS, 2020, 298 (01) : 117 - 133
  • [15] Sensitization of human osteosarcoma cells to Vγ9Vδ2 T-cell-mediated cytotoxicity by zoledronate
    Li, Zhaoxu
    Peng, Huiqin
    Xu, Qiang
    Ye, Zhaoming
    JOURNAL OF ORTHOPAEDIC RESEARCH, 2012, 30 (05) : 824 - 830
  • [16] Highly specific and potently activating Vγ9Vδ2-T cell specific nanobodies for diagnostic and therapeutic applications
    de Bruin, Renee C. G.
    Lougheed, Sinead M.
    van der Kruk, Liza
    Stam, Anita G.
    Hooijberg, Erik
    Roovers, Rob C.
    Henegouwen, Paul M. P. van Bergen En
    Verheul, Henk M. W.
    de Gruijl, Tanja D.
    van der Vliet, Hans J.
    CLINICAL IMMUNOLOGY, 2016, 169 : 128 - 138
  • [17] Targeting myeloma–osteoclast interaction with Vγ9Vδ2 T cells
    Qu Cui
    Hironobu Shibata
    Asuka Oda
    Hiroe Amou
    Ayako Nakano
    Kenichiro Yata
    Masahiro Hiasa
    Keiichiro Watanabe
    Shingen Nakamura
    Hirokazu Miki
    Takeshi Harada
    Shiro Fujii
    Kumiko Kagawa
    Kyoko Takeuchi
    Shuji Ozaki
    Toshio Matsumoto
    Masahiro Abe
    International Journal of Hematology, 2011, 94 : 63 - 70
  • [18] Mistletoe-Extract Drugs Stimulate Anti-Cancer Vγ9Vδ2 T Cells
    Ma, Ling
    Phalke, Swati
    Stevigny, Caroline
    Souard, Florence
    Vermijlen, David
    CELLS, 2020, 9 (06) : 1 - 15
  • [19] Targeting myeloma-osteoclast interaction with Vγ9Vδ2 T cells
    Cui, Qu
    Shibata, Hironobu
    Oda, Asuka
    Amou, Hiroe
    Nakano, Ayako
    Yata, Kenichiro
    Hiasa, Masahiro
    Watanabe, Keiichiro
    Nakamura, Shingen
    Miki, Hirokazu
    Harada, Takeshi
    Fujii, Shiro
    Kagawa, Kumiko
    Takeuchi, Kyoko
    Ozaki, Shuji
    Matsumoto, Toshio
    Abe, Masahiro
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2011, 94 (01) : 63 - 70
  • [20] Targeted Activation of Human Vγ9Vδ2-T Cells Controls Epstein-Barr Virus-Induced B Cell Lymphoproliferative Disease
    Xiang, Zheng
    Liu, Yinping
    Zheng, Jian
    Liu, Ming
    Lv, Aizhen
    Gao, Yulong
    Hu, Huaidong
    Lam, Kowk-Tai
    Chan, Godfrey Chi-Fung
    Yang, Yuanzhong
    Chen, Honglin
    Tsao, George Sai-Wah
    Bonneville, Marc
    Lau, Yu-Lung
    Tu, Wenwei
    CANCER CELL, 2014, 26 (04) : 565 - 576